What is Eikon Therapeutics, Inc. 's total equity?

Eikon Therapeutics, Inc. (EIKN) reported total equity of $550.67M in Q1 2026.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Cabot CorporationCBT

$1.57B+9.9%

UnifirstUNF

$2.18B+1.9%

Main Street CapitalMAIN

$3.09B+8.9%

BeldenBDC

$1.28B+4.9%

SSR MiningSSRM

$3.63B+14.6%

NNN REITNNN

$4.4B+0.9%

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$514.86M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's total equity?: Eikon Therapeutics, Inc. (EIKN) reported total equity of $550.67M in Q1 2026.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.